Pre-eclampsia markers (sFlt-1 PlGF)
Code:
SFLTPLGF
Sample Type:
Serum in standard or gel tubes (yellow top)
Ref Ranges/Units:
sFlt-1 ng/L (0-9184)
PlGF ng/L (0-1297)
sFLT-1 / PlGF ratio <38
Turnaround:
6 hours
Special Precautions/Comments:
Available on QE Gateshead and Sunderland hospital sites only. Phone lab when sending sample. Requires urgent centrifugation and freezing if samples not analysed immediately. Freeze only once.
Additional Information:
Preeclampsia (PE) is a serious complication of pregnancy characterized by hypertension and proteinuria after 20 weeks of gestation. Preeclampsia occurs in 3-5% of pregnancies and results in substantial maternal and fetal or neonatal mortality and morbidity. Clinical manifestations can vary from mild to severe forms; preeclampsia is still one of the leading causes of fetal and maternal morbidity and mortality.
The ratio of sFIt-1 to PIGF has been shown to be a better predictor of preeclampsia than either measure alone. The sFlt-i/PIGF ratio seems a reliable tool for discriminating between different types of pregnancy-related hypertensive disorders. In addition, sFlt-l/PICF has potential relevance as a prognostic parameter in PE and may be useful in prediction of preeclampsia and related maternal and fetal adverse outcomes, risk stratification and management.